The global robot-assisted endoscope market size was estimated to be USD 1.35 billion in 2023 and is expected to reach at USD 3.22 billion by 2034 with a CAGR of 8.23% during the forecast period 2024-2034. Rising focus towards enhancing robot-assisted endoscope systems, growing advancements in robotics & endoscopy, increasing prevalence of chronic diseases such as cancer, gastrointestinal disorders, & infectious diseases, surge in investments in endoscopic visualization systems, and rising regulatory support for various robotic endoscopic platforms are some of the key factors boosting the market growth.
Rising regulatory support for various robotic endoscopic platforms is predicted to boost the market growth during the forecast period. Contemporary robot-assisted endoscope systems feature cutting-edge imaging and sensor technologies. These systems utilize high-definition cameras and advanced sensors to provide real-time, high-resolution visualization of the patient's internal anatomy. Such detailed imagery is crucial for precise diagnostics and interventions. Leveraging these advancements, healthcare providers can elevate their level of care, leading to a growing demand for robot-assisted endoscopy. For instance, in January 2024, AnX Robotica has been granted de novo clearance by the FDA for its NaviCam ProScan, an artificial intelligence (AI)-aided endoscopy tool.
By product, therapeutic was the highest revenue-grossing segment in the global robot-assisted endoscope market in 2023 owing to the increase in the popularity of minimally invasive endoscopic procedures because of their shorter hospital stays and faster recovery times. Additionally, diagnostic is predicted to grow at the fastest CAGR during the forecast period owing to the increasing emphasis on developing innovative devices, accompanied by a surge in the introduction of novel systems. For instance, in October 2023, Olympus Corporation has unveiled the release of its latest EVIS X1 endoscopy system to the market.
By application, laparoscopy was the highest revenue-grossing segment in the global robot-assisted endoscope market in 2023 owing to the growing prevalence of bowel diseases, rising preference towards laparoscopic methods, expanding innovations in laparoscopy, surge in demand for minimally invasive therapeutic interventions, and growing diabetes prevalence. Additionally, bronchoscopy is predicted to grow at the fastest CAGR during the forecast period owing to the rise in infectious diseases, advancements in bronchoscope technology, and increase in the approval of innovative platforms. For instance, in May 2022, The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for endourological operations to Auris Health, Inc., a subsidiary of Ethicon, Inc., a Johnson & Johnson MedTech companies. With this approval, MONARCH becomes the initial and sole flexible robotic solution for use in both bronchoscopy and urology across various specialties.
By end-user, outpatient facilities was the highest revenue-grossing segment in the global robot-assisted endoscope market in 2023 owing to the growing demand for minimally invasive procedures and an increasing inclination towards cost-effective outpatient facilities. Additionally, hospitals is predicted to grow at the fastest CAGR during the forecast period owing to the increasing occurrence of chronic diseases such as gastrointestinal disorders & other ailments requiring endoscopic procedures, coupled with the rising adoption of advanced systems within hospital settings. For instance, in August 2022, EndoQuest Robotics has introduced its Endoluminal Surgical System (ELS) at Brigham and Women's Hospital in Boston. This robotic surgical instrument, called the ELS system, allows gastroenterologists and physicians specializing in therapeutic endoscopy to perform upper and lower gastrointestinal procedures without causing visible scars, utilizing either a trans-anal or trans-oral approach. These efforts contribute to sustaining competitiveness within the market.
North America region is anticipated for the highest revenue share during the forecast period owing to the presence of a robust healthcare sector, rising investments in state-of-the-art medical technologies such as robotic-assisted endoscopies, increasing public awareness about robot-assisted medical interventions, and enhanced collaborations among industry stakeholders. For instance, in May 2022, Creo Medical Group plc, a medical device company specializing in surgical endoscopy, has announced a long-term collaboration agreement with Intuitive to enhance specific Creo products for compatibility with Intuitive's robotic technology. Intuitive, a worldwide leader in minimally invasive healthcare technology and a trailblazer in robotic-assisted surgery, is the partner in this collaboration. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the rising adoption of advanced technologies, growing incidence of chronic diseases, expanded utilization of robotic systems within healthcare institutions, and surge in the introduction of sophisticated medical devices. For instance, in January 2023, Fujifilm has broadened its range of endoscopy solutions geared towards therapeutic gastrointestinal uses by introducing the ClutchCutter and FushKnife. With these additions, Fujifilm will provide a complete lineup of endoscopy products.
Rising regulatory support for various robotic endoscopic platforms is predicted to boost the market growth during the forecast period. Contemporary robot-assisted endoscope systems feature cutting-edge imaging and sensor technologies. These systems utilize high-definition cameras and advanced sensors to provide real-time, high-resolution visualization of the patient's internal anatomy. Such detailed imagery is crucial for precise diagnostics and interventions. Leveraging these advancements, healthcare providers can elevate their level of care, leading to a growing demand for robot-assisted endoscopy. For instance, in January 2024, AnX Robotica has been granted de novo clearance by the FDA for its NaviCam ProScan, an artificial intelligence (AI)-aided endoscopy tool.
By product, therapeutic was the highest revenue-grossing segment in the global robot-assisted endoscope market in 2023 owing to the increase in the popularity of minimally invasive endoscopic procedures because of their shorter hospital stays and faster recovery times. Additionally, diagnostic is predicted to grow at the fastest CAGR during the forecast period owing to the increasing emphasis on developing innovative devices, accompanied by a surge in the introduction of novel systems. For instance, in October 2023, Olympus Corporation has unveiled the release of its latest EVIS X1 endoscopy system to the market.
By application, laparoscopy was the highest revenue-grossing segment in the global robot-assisted endoscope market in 2023 owing to the growing prevalence of bowel diseases, rising preference towards laparoscopic methods, expanding innovations in laparoscopy, surge in demand for minimally invasive therapeutic interventions, and growing diabetes prevalence. Additionally, bronchoscopy is predicted to grow at the fastest CAGR during the forecast period owing to the rise in infectious diseases, advancements in bronchoscope technology, and increase in the approval of innovative platforms. For instance, in May 2022, The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for endourological operations to Auris Health, Inc., a subsidiary of Ethicon, Inc., a Johnson & Johnson MedTech companies. With this approval, MONARCH becomes the initial and sole flexible robotic solution for use in both bronchoscopy and urology across various specialties.
By end-user, outpatient facilities was the highest revenue-grossing segment in the global robot-assisted endoscope market in 2023 owing to the growing demand for minimally invasive procedures and an increasing inclination towards cost-effective outpatient facilities. Additionally, hospitals is predicted to grow at the fastest CAGR during the forecast period owing to the increasing occurrence of chronic diseases such as gastrointestinal disorders & other ailments requiring endoscopic procedures, coupled with the rising adoption of advanced systems within hospital settings. For instance, in August 2022, EndoQuest Robotics has introduced its Endoluminal Surgical System (ELS) at Brigham and Women's Hospital in Boston. This robotic surgical instrument, called the ELS system, allows gastroenterologists and physicians specializing in therapeutic endoscopy to perform upper and lower gastrointestinal procedures without causing visible scars, utilizing either a trans-anal or trans-oral approach. These efforts contribute to sustaining competitiveness within the market.
North America region is anticipated for the highest revenue share during the forecast period owing to the presence of a robust healthcare sector, rising investments in state-of-the-art medical technologies such as robotic-assisted endoscopies, increasing public awareness about robot-assisted medical interventions, and enhanced collaborations among industry stakeholders. For instance, in May 2022, Creo Medical Group plc, a medical device company specializing in surgical endoscopy, has announced a long-term collaboration agreement with Intuitive to enhance specific Creo products for compatibility with Intuitive's robotic technology. Intuitive, a worldwide leader in minimally invasive healthcare technology and a trailblazer in robotic-assisted surgery, is the partner in this collaboration. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the rising adoption of advanced technologies, growing incidence of chronic diseases, expanded utilization of robotic systems within healthcare institutions, and surge in the introduction of sophisticated medical devices. For instance, in January 2023, Fujifilm has broadened its range of endoscopy solutions geared towards therapeutic gastrointestinal uses by introducing the ClutchCutter and FushKnife. With these additions, Fujifilm will provide a complete lineup of endoscopy products.
Report Scope:
- Base Year: 2023
- Forecast Period: 2024-2034
Study Coverage
- Market Forecast by Type, Material, Product, and End-user
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of Top 10+ Major Market Players
- 20% Free Customization Available to Meet Your Exact Requirement.
Segmentation: Robot-Assisted Endoscope Market Report 2023 - 2034
Robot-Assisted Endoscope Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Bn)
- Therapeutic
- Diagnostic
Robot-Assisted Endoscope Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)
- Bronchoscopy
- Colonoscopy
- Laparoscopy
- Others
Robot-Assisted Endoscope Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)
- Outpatient Facilities
- Hospitals
Robot-Assisted Endoscope Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Robot-Assisted Endoscope Market: Product Estimates & Trend Analysis
8. Robot-Assisted Endoscope Market: Application Estimates & Trend Analysis
9. Robot-Assisted Endoscope Market: End-user Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Robot-Assisted Endoscope Market
12. Europe Robot-Assisted Endoscope Market
13. Asia Pacific Robot-Assisted Endoscope Market
14. Latin America Robot-Assisted Endoscope Market
15. MEA Robot-Assisted Endoscope Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- Johnson & Johnson Services Inc.
- Boston Scientific Corporation
- Asensus Surgical US Inc.
- Auris Health Inc.
- Intuitive Surgical
- Medtronic plc.
- Brainlab AG
- Stryker
